Exploring new methods for chemical reactions using palladium and norbornene.
New Directions in Palladium/Norbornene Cooperative-Renewal
This study is exploring new ways to use a special catalyst to make important chemical reactions easier and more efficient, which could help create better medicines for people.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11073071 on NIH RePORTER |
What this research studies
This research focuses on developing innovative palladium/norbornene (Pd/NBE) catalysis techniques to enhance chemical reactions that are crucial for creating complex molecules, particularly in pharmaceuticals. The team aims to achieve unprecedented reactions, such as the ortho oxygenation of aryl halides and the vicinal difunctionalization of heteroarenes. By identifying new synthetic methods and efficient catalyst systems, this research could lead to the production of poly-substituted arenes and heterocycles, which are important in drug development.
Who could benefit from this research
Good fit: Patients who may benefit from this research are those with conditions that could be treated by new pharmaceuticals developed through these innovative chemical methods.
Not a fit: Patients who are not seeking new treatment options or those with conditions that do not require novel drug development may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly improve the efficiency and effectiveness of drug discovery processes.
How similar studies have performed: Similar research in the field of catalysis has shown promising results, indicating that this approach could lead to significant advancements in chemical synthesis.
Where this research is happening
Chicago, United States
- University of Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Dong, Guangbin — University of Chicago
- Study coordinator: Dong, Guangbin
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.